A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Pergolide
Saruplase
The risk or severity of bleeding can be increased when Saruplase is combined with Bosutinib.
Pergolide
Melagatran
The risk or severity of bleeding can be increased when Melagatran is combined with Bosutinib.
Pergolide
Tioclomarol
The risk or severity of bleeding can be increased when Tioclomarol is combined with Bosutinib.
Pergolide
Brinase
The risk or severity of bleeding can be increased when Brinase is combined with Bosutinib.
Pergolide
Protein S human
The risk or severity of bleeding can be increased when Protein S human is combined with Bosutinib.
Pergolide
Gabexate
The risk or severity of bleeding can be increased when Gabexate is combined with Bosutinib.
Pergolide
Monteplase
The risk or severity of bleeding can be increased when Monteplase is combined with Bosutinib.
Pergolide
Nafamostat
The risk or severity of bleeding can be increased when Nafamostat is combined with Bosutinib.
Pergolide
Darexaban
The risk or severity of bleeding can be increased when Darexaban is combined with Bosutinib.
Pergolide
Letaxaban
The risk or severity of bleeding can be increased when Letaxaban is combined with Bosutinib.
Pergolide
Antithrombin III human
The risk or severity of bleeding can be increased when Antithrombin III human is combined with Bosutinib.
Pergolide
Protein C
The risk or severity of bleeding can be increased when Protein C is combined with Bosutinib.
Pergolide
Antithrombin Alfa
The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Bosutinib.
Pergolide
Zinc citrate
The risk or severity of bleeding can be increased when Zinc citrate is combined with Bosutinib.
Pergolide
Desirudin
The risk or severity of bleeding can be increased when Desirudin is combined with Bosutinib.
Pergolide
Parnaparin
The risk or severity of bleeding can be increased when Parnaparin is combined with Bosutinib.
Pergolide
Bemiparin
The risk or severity of bleeding can be increased when Bemiparin is combined with Bosutinib.
Pergolide
Dextran
The risk or severity of bleeding can be increased when Dextran is combined with Bosutinib.
Pergolide
Sodium citrate
The risk or severity of bleeding can be increased when Sodium citrate is combined with Bosutinib.
Pergolide
Potassium citrate
The risk or severity of bleeding can be increased when Potassium citrate is combined with Bosutinib.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3